Zinc Status Biomarkers and Cardiometabolic Risk Factors in Metabolic Syndrome: A Case Control Study

Zinc Status Biomarkers and Cardiometabolic Risk Factors in Metabolic Syndrome: A Case Control Study

Metabolic syndrome (MS) involves pathophysiological alterations that might compromise zinc status. The aim of this study was to evaluate zinc status biomarkers and their associations with cardiometabolic factors in patients with MS. Our case control study included 88 patients with MS and 37 controls...

Full description

Bibliographic Details
Main Authors: Erika P. S. Freitas, Aline T. O. Cunha, Sephora L. S. Aquino, Lucia F. C. Pedrosa, Severina C. V. C. Lima, Josivan G. Lima, Maria G. Almeida, Karine C. M. Sena-Evangelista
Format: Article
Language:English
Published: MDPI AG 2017-02-01
Series:Nutrients
Subjects:
metabolic syndrome
zinc
biomarkers
risk factors
cardiovascular diseases
Online Access:http://www.mdpi.com/2072-6643/9/2/175

Similar Items

Similar Items